# Maximum Alveolar Concentration of Sevoflurane for Maintaining Effective Spontaneous Respiration

> **NCT05611411** · — · UNKNOWN · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 70 (estimated)

## Conditions studied

- Sevoflurane

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05611411
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-11-03
- **Final completion:** 2023-12-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611411, "Maximum Alveolar Concentration of Sevoflurane for Maintaining Effective Spontaneous Respiration". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05611411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*